Ifrah Financial Services, Inc. Charles River Laboratories International, Inc. Transaction History

Ifrah Financial Services, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 03, 2022	SELL	$255.51 - $362.11 $168,892 - $239,354	-661 Closed	0 $0
Q4 2021 Feb 01, 2022	BUY	$351.38 - $448.68 $1,405 - $1,794	4 Added 0.61%	661 $249,000
Q3 2021 Nov 01, 2021	SELL	$372.64 - $458.3 $1,490 - $1,833	-4 Reduced 0.61%	657 $271,000
Q2 2021 Aug 05, 2021	BUY	$294.17 - $371.65 $194,446 - $245,660	661 New	661 $244,000

696

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.88B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Ifrah Financial Services, Inc., based on Form 13F filings with the SEC.

Stay updated on Ifrah Financial Services, Inc. with notifications on news.